Abstract
The pharmacokinetics of cinoxacin, a new antibacterial compound related to nalidixic acid and oxolinic acid, were investigated in 22 patients with varying degrees of renal impairment. After oral administration of cinoxacin at 500 mg every 12 h for 7 days to all patients, the drug was found to be well tolerated. The urine concentrations of cinoxacin in all patients far exceeded the minimal inhibitory concentrations for susceptible organisms commonly found in urinary tract infections. The serum half-life of cinoxacin in patients with normal renal function was approximately 2.7 h but increased to approximately 8.5 h in patients with creatinine clearance less than 30 ml/min. No undue drug accumulation was demonstrated in any patient group during the treatment. Highly significant correlations were found between the elimination rate constant and creatinine clearance and also between the elimination half-life and serum creatinine. The bioavailability of cinoxacin was independent of renal function.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Black H. R., Israel K. S., Wolen R. L., Brier G. L., Obermeyer B. D., Ziege E. A., Wolny J. D. Pharmacology of cinoxacin in humans. Antimicrob Agents Chemother. 1979 Feb;15(2):165–170. doi: 10.1128/aac.15.2.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burt R. A., Morgan T., Payne J. P., Bonner R. M. Cinoxacin concentrations in plasma, urine and prostatic tissue after oral administration to man. Br J Urol. 1977 Apr;49(2):147–152. doi: 10.1111/j.1464-410x.1977.tb04089.x. [DOI] [PubMed] [Google Scholar]
- Giamarellou H., Jackson G. G. Antibacterial activity of cinoxacin in vitro. Antimicrob Agents Chemother. 1975 May;7(5):688–692. doi: 10.1128/aac.7.5.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kurtz S., Turck M. In vitro activity of cinoxacin, an organic acid antibacterial. Antimicrob Agents Chemother. 1975 Mar;7(3):370–373. doi: 10.1128/aac.7.3.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Landes R. R., Hall J. W. Cinoxacin: new antimicrobial agent for urinary tract infections. Urology. 1977 Oct;10(4):312–316. doi: 10.1016/0090-4295(77)90157-1. [DOI] [PubMed] [Google Scholar]
- Lumish R. M., Norden C. W. Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid. Antimicrob Agents Chemother. 1975 Feb;7(2):159–163. doi: 10.1128/aac.7.2.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Panwalker A. P., Giamarellou H., Jackson G. G. Efficacy of cinoxacin in urinary tract infections. Antimicrob Agents Chemother. 1976 Mar;9(3):502–505. doi: 10.1128/aac.9.3.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stamey T. A., Bragonje J. Resistance to nalidixic acid. A misconception due to underdosage. JAMA. 1976 Oct 18;236(16):1857–1860. [PubMed] [Google Scholar]